454 related articles for article (PubMed ID: 14694168)
21. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
[TBL] [Abstract][Full Text] [Related]
22. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
23. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.
Donadio JV; Grande JP; Bergstralh EJ; Dart RA; Larson TS; Spencer DC
J Am Soc Nephrol; 1999 Aug; 10(8):1772-7. PubMed ID: 10446945
[TBL] [Abstract][Full Text] [Related]
24. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
25. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
[TBL] [Abstract][Full Text] [Related]
26. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
[TBL] [Abstract][Full Text] [Related]
27. Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy.
Watanabe-Kusunoki K; Nakazawa D; Yamamoto J; Matsuoka N; Kaneshima N; Nakagaki T; Yamamoto R; Maoka T; Iwasaki S; Tsuji T; Fukasawa Y; Nishimoto N; Nishio S; Atsumi T
Medicine (Baltimore); 2021 Dec; 100(50):e27778. PubMed ID: 34918629
[TBL] [Abstract][Full Text] [Related]
28. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor.
Oka K; Imai E; Moriyama T; Akagi Y; Ando A; Hori M; Okuyama A; Toki K; Kyo M; Kokado Y; Takahara S
Nephrol Dial Transplant; 2000 May; 15(5):689-95. PubMed ID: 10809812
[TBL] [Abstract][Full Text] [Related]
29. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
30. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
32. The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy.
Hirano K; Kawamura T; Tsuboi N; Okonogi H; Miyazaki Y; Ikeda M; Matsushima M; Hanaoka K; Ogura M; Utsunomiya Y; Hosoya T
Clin Exp Nephrol; 2013 Aug; 17(4):555-62. PubMed ID: 23224025
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
Rauta V; Finne P; Fagerudd J; Rosenlöf K; Törnroth T; Grönhagen-Riska C
Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
[TBL] [Abstract][Full Text] [Related]
34. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
35. Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.
Messina M; di Vico MC; Ariaudo C; Mazzucco G; Fop F; Segoloni GP; Biancone L
J Nephrol; 2016 Aug; 29(4):575-83. PubMed ID: 27217158
[TBL] [Abstract][Full Text] [Related]
36. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
Gao R; Wu W; Wen Y; Li X
Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroid therapy in IgA nephropathy.
Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H;
J Am Soc Nephrol; 2012 Jun; 23(6):1108-16. PubMed ID: 22539830
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
39. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
Tan L; Tang Y; Peng W; Mathew BS; Qin W
Kidney Blood Press Res; 2018; 43(4):1333-1343. PubMed ID: 30099439
[TBL] [Abstract][Full Text] [Related]
40. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
Shimizu A; Takei T; Uchida K; Tsuchiya K; Nitta K
Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
